A Perspective on the Clinical Translation of Scaffolds for Tissue Engineering
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Scaffolds have been broadly applied within tissue engineering and regenerative medicine to regenerate, replace, or augment diseased or damaged tissue. For a scaffold to perform optimally, several design considerations must be addressed, with an eye toward the eventual form, function, and tissue site. The chemical and mechanical properties of the scaffold must be tuned to optimize the interaction with cells and surrounding tissues. For complex tissue engineering, mass transport limitations, vascularization, and host tissue integration are important considerations. As the tissue architecture to be replaced becomes more complex and hierarchical, scaffold design must also match this complexity to recapitulate a functioning tissue. We outline these design constraints and highlight creative and emerging strategies to overcome limitations and modulate scaffold properties for optimal regeneration. We also highlight some of the most advanced strategies that have seen clinical application and discuss the hurdles that must be overcome for clinical use and commercialization of tissue engineering technologies. Finally, we provide a perspective on the future of scaffolds as a functional contributor to advancing tissue engineering and regenerative medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Langer, R., & Vacanti, J. P. (1993) · Science · doi:10.1126/science.8493529 · Cited by 9,893
Self-citationOdian, G. (2004) · doi:10.1002/047147875x · Cited by 7,158
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566 · cited 1×
“8 billion after capitalization.(110) It is less clear what the cost may be for a tissue engineered therapy, but it could be considerably higher when additional components (i.”
BackgroundGenomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Mesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart
Ott, H. C., Matthiesen, T. S., Goh, S.-K., Black, L. D., Kren, S. M., Netoff, T. I., & Taylor, D. A. (2008) · Nature Medicine · doi:10.1038/nm1684 · Cited by 2,650
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues
Miller, J. S., Stevens, K. R., Yang, M. T., Baker, B. M., Nguyen, D.-H. T., Cohen, D. M., Toro, E., Chen, A. A., Galie, P. A., Yu, X., et al. (2012) · Nature Materials · doi:10.1038/nmat3357 · Cited by 1,917
Scaffolding in tissue engineering: general approaches and tissue-specific considerations
Chan, B. P., & Leong, K. W. (2008) · European Spine Journal · doi:10.1007/s00586-008-0745-3 · Cited by 1,708
Uygun, B. E., Soto-Gutierrez, A., Yagi, H., Izamis, M.-L., Guzzardi, M. A., Shulman, C., Milwid, J., Kobayashi, N., Tilles, A., Berthiaume, F., et al. (2010) · Nature Medicine · doi:10.1038/nm.2170 · Cited by 1,370
Cited by
Materials design for bone-tissue engineering
Koons, G. L., Diba, M., & Mikos, A. G. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-0204-2 · Cited by 1,699
Webber, M. J., Appel, E. A., Meijer, E. W., & Langer, R. (2016) · Nature Materials · doi:10.1038/nmat4474 · Cited by 1,605
Self-citation3D bioactive composite scaffolds for bone tissue engineering
Turnbull, G., Clarke, J., Picard, F., Riches, P., Jia, L., Han, F., Li, B., & Shu, W. (2018) · Bioactive Materials · doi:10.1016/j.bioactmat.2017.10.001 · Cited by 1,332
Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors
Morsut, L., Roybal, K. T., Xiong, X., Gordley, R. M., Coyle, S. M., Thomson, M., & Lim, W. A. (2016) · Cell · doi:10.1016/j.cell.2016.01.012 · Cited by 1,000
Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment
Huang, G., Li, F., Zhao, X., Ma, Y., Li, Y., Lin, M., Jin, G., Lu, T. J., Genin, G. M., & Xu, F. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00094 · Cited by 825
Nam, S., & Mooney, D. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00798 · Cited by 764
Graphene-based materials for tissue engineering
Shin, S. R., Li, Y.-C., Jang, H. L., Khoshakhlagh, P., Akbari, M., Nasajpour, A., Zhang, Y. S., Tamayol, A., & Khademhosseini, A. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.007 · Cited by 721
Bone biomaterials and interactions with stem cells
Gao, C., Peng, S., Feng, P., & Shuai, C. (2017) · Bone Research · doi:10.1038/boneres.2017.59 · Cited by 720
Bioprinting for vascular and vascularized tissue biofabrication
Datta, P., Ayan, B., & Ozbolat, I. T. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.035 · Cited by 431
Advances in Extrusion 3D Bioprinting: A Focus on Multicomponent Hydrogel‐Based Bioinks
Cui, X., Li, J., Hartanto, Y., Durham, M., Tang, J., Zhang, H., Hooper, G., Lim, K., & Woodfield, T. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901648 · Cited by 383
Biomedical Applications of Recombinant Silk‐Based Materials
Aigner, T. B., DeSimone, E., & Scheibel, T. (2018) · Advanced Materials · doi:10.1002/adma.201704636 · Cited by 318
Regenerative Medicine for Periodontal and Peri-implant Diseases
Larsson, L., Decker, A. M., Nibali, L., Pilipchuk, S. P., Berglundh, T., & Giannobile, W. V. (2016) · Journal of Dental Research · doi:10.1177/0022034515618887 · Cited by 300
Lutzweiler, G., Ndreu Halili, A., & Engin Vrana, N. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070602 · Cited by 271
Alvarez, M. M., Liu, J. C., Trujillo-de Santiago, G., Cha, B.-H., Vishwakarma, A., Ghaemmaghami, A. M., & Khademhosseini, A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.026 · Cited by 256
Design of spherically structured 3D in vitro tumor models -Advances and prospects
Ferreira, L. P., Gaspar, V. M., & Mano, J. F. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.034 · Cited by 249
JetValve: Rapid manufacturing of biohybrid scaffolds for biomimetic heart valve replacement
Capulli, A. K., Emmert, M. Y., Pasqualini, F. S., Kehl, D., Caliskan, E., Lind, J. U., Sheehy, S. P., Park, S. J., Ahn, S., Weber, B., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.033 · Cited by 112
Harrison, R. P., Ruck, S., Medcalf, N., & Rafiq, Q. A. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.07.005 · Cited by 72
“This could consist of an approved off-the-shelf synthetic polymer such as polyethylene glycol (PEG) [40], poly(lactic-co-glycolic acid) (PLGA) [41], polycaprolactone (PCL), and ultra-high molecular weight polyethylene (UHMWPE) [42] or alternatively a naturally derived polymer [43] or patient tissue [44].”
BackgroundLiver Tissue Engineering as an Emerging Alternative for Liver Disease Treatment
Mirdamadi, E. S., Kalhori, D., Zakeri, N., Azarpira, N., & Solati-Hashjin, M. (2020) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2019.0233 · Cited by 57
Metadata
- Authors
- Webber, M. J., Khan, O. F., Sydlik, S. A., Tang, B. C., & Langer, R.
- Venue
- Annals of Biomedical Engineering
- Published
- 2014-09-09
- Volume
- 43
- Issue
- 3
- Pages
- 641-656
- ISSN
- 0090-6964 (ISSN-L)
- 1573-9686
- OpenAlex
- W2013100565
- Cited by
- 243
- References
- 25
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.